Endo to Announce Fourth Quarter 2015 Financial Results on February 29, 2016

DUBLIN, Feb. 16, 2016 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) (TSX: ENL) will announce its fourth quarter 2015 financial results before the open of the U.S. financial markets on February 29, 2016 and members of its senior management team will host a conference call and webcast at 8:30 a.m. ET that day.

The dial-in number to access the call is U.S./Canada (877) 456-0441, International (929) 387-3793, and the passcode is 50028537. Please dial in 10 minutes prior to the scheduled start time.

A replay of the call will be available from February 29, 2016 at 12:30 p.m. ET until 11:59 p.m. ET on March 14, 2016 by dialing (404) 537-3406 (U.S./Canada) or (855) 859-2056 (International) and entering the passcode 50028537.

A simultaneous webcast of the call can be accessed by visiting www.endo.com. In addition, a replay of the webcast will be available until 11:59 p.m. ET on March 14, 2016. The replay can be accessed by clicking on "Events" in the Investor Relations section of the website.

About Endo International plc
Endo International plc (NASDAQ: ENDP) (TSX: ENL) is a global specialty pharmaceutical company focused on improving patients' lives while creating shareholder value. Endo develops, manufactures, markets and distributes quality branded and generic pharmaceutical products as well as over-the-counter medications though its operating companies. Endo has global headquarters in Dublin, Ireland, and U.S. headquarters in Malvern, PA. Learn more at www.endo.com.

SOURCE Endo Pharmaceuticals Inc.

Related Links

http://www.endo.com